Devising Biocompatible, NIRâActivated Helical Pyroptosis Agents via đâTwisting Strategy for Promoting Antitumor Immunity
Small · 2024
DOI: 10.1002/smll.202405496 âKurz gefasst
Fachartikel in der Zeitschrift Small, 2024. Verfasst von Xiaoqian Shi und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, Key Laboratory of Functional Polymer Materials of Ministry of Education, NanâŠ. Hauptthemen laut MEDLINE: Pyroptosis, Biocompatible Materials. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 73 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Tianjin of China, Fundamental Research Funds for the Central Universities (Nankai University).
Abstract (Originalsprache)
Specifically controlling cell pyroptosis is advantageous for oncotherapy as it allows simultaneous ablation of primary tumors and activation of immunogenicity of tumor environment. Herein, a facile and robust strategy is presented to construct efficient NIRâactivated helical pyroptosis agents (PyroAs) with negligible dark cytotoxicity. It is demonstrated that the construction of four intramolecular BâX bonds (X = O or N) within the BODIPY chromophore enforces a significant twisting of its Ïâconjugation, yielding a variety of helical H BD molecules with desired high photosensitivity and negligible dark toxicity. A robust approach is established to extend H BD into the nearâinfrared (NIR) region through siteâselective incorporation of an electronâwithdrawing ester moiety. It is also proved that targeted delivery of the NIRâactivated H BDâER to the endoplasmic reticulum (ER) specifically activates pyroptosis pathway by equipping it with an ERâtargeting moiety. Finally, the favorable biocompatibility, excellent antitumor efficacy, and remarkable systematic immune response of this unique NIRâactivated helical PyroAs are shown in vivo, demonstrating its potential application in solid tumor immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, Key Laboratory of Functional Polymer Materials of Ministry of Education, Nankai University, Tianjin, 300071, China.
ORCID-Profile: Changhua Li
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Tianjin of China
- Fundamental Research Funds for the Central Universities (Nankai University)
Zitieren
APA
Shi, X., Wang, Y., Qi, F., Zhang, H., Cao, Y., Xu, X., Liu, W., & Li, C. (2024). Devising Biocompatible, NIRâActivated Helical Pyroptosis Agents via đâTwisting Strategy for Promoting Antitumor Immunity. Small. https://doi.org/10.1002/smll.202405496
Vancouver
Shi X, Wang Y, Qi F, Zhang H, Cao Y, Xu X, et al. Devising Biocompatible, NIRâActivated Helical Pyroptosis Agents via đâTwisting Strategy for Promoting Antitumor Immunity. Small. 2024. doi:10.1002/smll.202405496
BibTeX
@article{Shi2024,
author = {Shi, Xiaoqian and Wang, Yaming and Qi, Fan and Zhang, Hao and Cao, Yahui and Xu, Xiaona and Liu, Weiqing and Li, Changhua},
title = {Devising Biocompatible, NIRâActivated Helical Pyroptosis Agents via đâTwisting Strategy for Promoting Antitumor Immunity},
journal = {Small},
year = {2024},
doi = {10.1002/smll.202405496}
}
EUVIMED